We are live on ! Find out more

Mid Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
MOH icon
1
Molina Healthcare
MOH
$9.96B
$9.96B $190.89 1.25%
BRKR icon
2
Bruker
BRKR
$9.78B
$9.78B $64.18 0.28%
HSIC icon
3
Henry Schein
HSIC
$9.62B
$9.62B $86.33 0.94%
PODD icon
4
Insulet
PODD
$9.44B
$9.44B $136.09 0.23%
KYMR icon
5
Kymera Therapeutics
KYMR
$9.31B
$9.31B $112.02 3.27%
ARWR icon
6
Arrowhead Research
ARWR
$9.31B
$9.31B $65.92 0.23%
PTGX icon
7
Protagonist Therapeutics
PTGX
$9.18B
$9.18B $141.82 3.26%
OSCR icon
8
Oscar Health
OSCR
$9.14B
$9.14B $29.60 2.53%
QGEN icon
9
Qiagen
QGEN
$9.12B
$9.12B $44.17 0.88%
GKOS icon
10
Glaukos
GKOS
$9.11B
$9.11B $154.40 0.31%
CAI
11
Caris Life Sciences
CAI
$9.04B
$9.04B $31.99 0.87%
CYTK icon
12
Cytokinetics
CYTK
$8.98B
$8.98B $64.62 1.58%
IBRX icon
13
ImmunityBio
IBRX
$8.95B
$8.95B $8.44 2.31%
TGTX icon
14
TG Therapeutics
TGTX
$8.78B
$8.78B $57.38 0.24%
PCVX icon
15
Vaxcyte
PCVX
$8.37B
$8.37B $56.26 1.12%
ABVX
16
Abivax
ABVX
$7.94B
$7.94B $91.05 4.03%
ATR icon
17
AptarGroup
ATR
$7.87B
$7.87B $123.81 0.35%
PRAX icon
18
Praxis Precision Medicines
PRAX
$7.85B
$7.85B $281.02 0.27%
HNGE
19
Hinge Health
HNGE
$7.71B
$7.71B $95.59 3.92%
SYRE icon
20
Spyre Therapeutics
SYRE
$7.56B
$7.56B $85.71 1.58%
IONS icon
21
Ionis Pharmaceuticals
IONS
$7.4B
$7.4B $44.51 1.6%
HQY icon
22
HealthEquity
HQY
$7.3B
$7.3B $88.25 0.4%
AMRX icon
23
Amneal Pharmaceuticals
AMRX
$6.89B
$6.89B $19.77 0.2%
IMVT icon
24
Immunovant
IMVT
$6.88B
$6.88B $33.32 2%
HIMS icon
25
Hims & Hers Health
HIMS
$6.87B
$6.87B $29.43 0.51%
1
2 3 4 5

Mid Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 156 mid cap Healthcare stocks — companies in the Healthcare sector with a market cap between $2B and $10B — worth a combined $696B.

The largest by market cap are Molina Healthcare (MOH) at $9.96B, Bruker (BRKR) at $9.78B and Henry Schein (HSIC) at $9.62B.

Among institutional investors, Definium Therapeutics (DFTX) drew the most net new fund positions in Q2 2026: 148 funds opened new positions, taking total fund holders up 114 (46%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.